1986年11月在伦敦召开了第六届国际偏头痛专题讨论会,关于偏头痛的治疗和预防的进展要点如下。丹麦对27名病人的研究报告表明,含0.5～1mg双氢麦角胺(DHE)的鼻喷雾剂被认为是临床效果好的药物。用1mg DHE治疗偏头痛病人,62％病人的反应是好的和比较好的;用0.5mg DHE治疗,治疗反应好和较好的是49％。相比之下,用安慰剂治疗的病人,只有33％的人反应 The Sixth International Migraine Symposium was held in London in November 1986 with the following highlights on the treatment and prevention of migraine. A study of 27 patients in Denmark showed that nasal sprays containing 0.5 to 1 mg of dihydroergotamine (DHE) are considered clinically effective. 62% of patients treated with 1 mg of DHE had better and better responses to migraine; 0.5% DHE had a good response and preferably 49%. In contrast, only 33% of patients treated with placebo responded